Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer

NCT07590570 is registered in ClinicalTrials.gov with Wenjin Yin as lead sponsor.

NCT NCT07590570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07590570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association of Lunula Status With the Efficacy and Safety of Neoadjuvant Therapy in Breast Cancer
Lead sponsor
Wenjin Yin
Phase
Observational
Overall status
Active, not recruiting
Start date
May 1, 2026
Completion date
January 31, 2033
Enrollment
188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer invasive